• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺转录因子-1、E-钙黏蛋白、BG8、WT1和CD44S免疫染色在鉴别上皮性胸膜间皮瘤与肺腺癌和非肺腺癌中的价值。

Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.

作者信息

Ordóñez N G

机构信息

University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

出版信息

Am J Surg Pathol. 2000 Apr;24(4):598-606. doi: 10.1097/00000478-200004000-00016.

DOI:10.1097/00000478-200004000-00016
PMID:10757409
Abstract

The distinction between malignant pleural mesotheliomas and adenocarcinomas, particularly those originating in the lung, is a difficult diagnostic problem that can be facilitated by the use of immunohistochemical markers. In this study, the immunoreactivity of thyroid transcription factor-1 (TTF-1), E-cadherin, BG8, WT1, and CD44S was investigated in 50 epithelial mesotheliomas, and 40 pulmonary and 95 nonpulmonary adenocarcinomas. After analyzing the results, it was concluded that E-cadherin and BG8 are useful markers for distinguishing between epithelial mesotheliomas and adenocarcinomas of various origins, including the lung. Because TTF-1 expression is found almost exclusively in adenocarcinomas of the lung but is absent in mesotheliomas, immunostaining for this marker is particularly useful for distinguishing between these two malignancies. Although WT1 immunostaining may also be useful, its value, as determined in this study, is lower than that reported by other investigators. CD44S immunostaining does not have any practical value in discriminating between epithelial mesothelioma and lung adenocarcinoma.

摘要

恶性胸膜间皮瘤与腺癌,尤其是起源于肺部的腺癌之间的鉴别,是一个棘手的诊断难题,而免疫组化标志物的应用有助于解决这一问题。在本研究中,我们检测了50例上皮性间皮瘤、40例肺腺癌和95例非肺腺癌中甲状腺转录因子-1(TTF-1)、E-钙黏蛋白、BG8、WT1和CD44S的免疫反应性。分析结果后得出结论,E-钙黏蛋白和BG8是区分上皮性间皮瘤与包括肺癌在内的各种起源腺癌的有用标志物。由于TTF-1表达几乎仅见于肺腺癌,而间皮瘤中不存在,因此该标志物的免疫染色对于区分这两种恶性肿瘤尤为有用。尽管WT1免疫染色可能也有用,但本研究确定其价值低于其他研究者报道的价值。CD44S免疫染色在鉴别上皮性间皮瘤和肺腺癌方面没有任何实际价值。

相似文献

1
Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.甲状腺转录因子-1、E-钙黏蛋白、BG8、WT1和CD44S免疫染色在鉴别上皮性胸膜间皮瘤与肺腺癌和非肺腺癌中的价值。
Am J Surg Pathol. 2000 Apr;24(4):598-606. doi: 10.1097/00000478-200004000-00016.
2
The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.间皮瘤的免疫组织化学诊断:上皮样间皮瘤与肺腺癌的对比研究
Am J Surg Pathol. 2003 Aug;27(8):1031-51. doi: 10.1097/00000478-200308000-00001.
3
Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.钙视网膜蛋白免疫染色在鉴别上皮性间皮瘤与肺腺癌中的价值。
Mod Pathol. 1998 Oct;11(10):929-33.
4
[Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study].[表面活性物质蛋白与甲状腺转录因子1在胸膜肺肿瘤中的表达。免疫组织化学研究]
Pathologica. 2000 Dec;92(6):496-502.
5
Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma.
Hum Pathol. 2003 Aug;34(8):749-55. doi: 10.1016/s0046-8177(03)00285-5.
6
Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma.MOC-31单克隆抗体在鉴别上皮性胸膜间皮瘤与肺腺癌中的价值。
Hum Pathol. 1998 Feb;29(2):166-9. doi: 10.1016/s0046-8177(98)90227-1.
7
TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma.TTF-1和表面活性蛋白B作为辅助诊断肺腺癌和胸膜间皮瘤的共同佐剂。
Ann Diagn Pathol. 2004 Dec;8(6):337-41. doi: 10.1053/j.anndiagpath.2004.08.003.
8
Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.免疫组织化学在恶性间皮瘤与肺腺癌鉴别诊断中的应用:对新型抗体的批判性评估
J Clin Pathol. 2002 Sep;55(9):662-8. doi: 10.1136/jcp.55.9.662.
9
Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.细胞角蛋白5/6免疫染色在鉴别胸膜上皮样间皮瘤与肺腺癌中的价值。
Am J Surg Pathol. 1998 Oct;22(10):1215-21. doi: 10.1097/00000478-199810000-00006.
10
Immunohistochemical diagnosis of epithelioid mesothelioma: an update.上皮样间皮瘤的免疫组织化学诊断:最新进展
Arch Pathol Lab Med. 2005 Nov;129(11):1407-14. doi: 10.5858/2005-129-1407-IDOEMA.

引用本文的文献

1
Case Report: Lung Adenocarcinoma Initially Presenting With Cutaneous and Subcutaneous Metastases.病例报告:以皮肤及皮下转移为首发表现的肺腺癌
Front Oncol. 2022 Jul 12;12:925382. doi: 10.3389/fonc.2022.925382. eCollection 2022.
2
Immunocytochemistry of effusion fluids: Introduction to SCIP approach.积液的免疫细胞化学:SCIP方法介绍
Cytojournal. 2022 Jan 31;19:3. doi: 10.25259/CMAS_02_05_2021. eCollection 2022.
3
Immunocytochemistry of effusions: Processing and commonly used immunomarkers.积液的免疫细胞化学:处理方法及常用免疫标志物
Cytojournal. 2022 Jan 31;19:6. doi: 10.25259/CMAS_02_15_2021. eCollection 2022.
4
Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms' Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49).使用新型N端靶向抗体(克隆WT49)评估成人肾细胞癌中威尔姆斯瘤1(WT1)抗原检测的既定作用、未来前景和方法学异质性
Biomedicines. 2022 Apr 15;10(4):912. doi: 10.3390/biomedicines10040912.
5
Metastatic Adenocarcinoma of the Lung Presenting as a Soft Tissue Mass.以软组织肿块形式表现的肺转移性腺癌
Case Rep Surg. 2021 Jan 6;2021:8856503. doi: 10.1155/2021/8856503. eCollection 2021.
6
A Rare Complication of Diffuse Malignant Peritoneal Mesothelioma: Spontaneous Ileal Perforation.弥漫性恶性腹膜间皮瘤的一种罕见并发症:自发性回肠穿孔。
Indian J Surg Oncol. 2019 Sep;10(3):465-469. doi: 10.1007/s13193-019-00916-7. Epub 2019 Apr 6.
7
Utilization of Wilms' tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas.威尔姆斯瘤1抗原在一组卵巢癌鉴别诊断中的应用
Turk J Obstet Gynecol. 2016 Mar;13(1):37-41. doi: 10.4274/tjod.22220. Epub 2016 Mar 10.
8
TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC).小细胞肺癌(SCLC)患者中 TTF-1- 和/或 CD56-阳性循环肿瘤细胞。
Sci Rep. 2017 Mar 28;7:45351. doi: 10.1038/srep45351.
9
Diagnosis and management of patients with malignant peritoneal mesothelioma.恶性腹膜间皮瘤患者的诊断与管理
J Gastrointest Oncol. 2016 Feb;7(1):79-86. doi: 10.3978/j.issn.2078-6891.2015.134.
10
Small cell carcinoma of the prostate.前列腺小细胞癌。
Nat Rev Urol. 2014 Apr;11(4):213-9. doi: 10.1038/nrurol.2014.21. Epub 2014 Feb 18.